Biocrucible Ltd

Active11614863 Private limited company

Incorporated: 10 October 2018 (8 years)
Industry: Research and experimental development on biotechnology (72110)
Directors: Anuv Ratan
Ali John Satvat
Accounts type: Full
Region: East of England
Address: The Emmanuel Building Suite 2
Chesterford Research Campus
Little Chesterford
Saffron Walden
CB10 1XL

Filing status

Accounts due: 31 December 2026
Last accounts: 31 December 2024
Conf. stmt due: 23 October 2027
Last conf. stmt: 9 October 2026

Charges

Total: 2
Outstanding: 1
Part satisfied: 0
Satisfied: 1

Officers 2 active

Officer details are public data from the Companies House register.

Ratan, Anuv

Director · Appointed 21 July 2021

American

Born April 1992 (34)

Satvat, Ali John

Director · Appointed 21 July 2021

American

Born September 1977 (49)

Officer history (5 former)

4 October 2026

Resigned Nawana, Namal as Director

18 September 2026

Resigned Gladwell, Mark as Director

12 May 2026

Resigned Armes, Niall Antony as Director

10 November 2023

Resigned Brooks, David Graham, Dr as Director

10 December 2021

Appointed Gladwell, Mark as Director

21 July 2021

Appointed Ratan, Anuv as Director

21 July 2021

Appointed Satvat, Ali John as Director

21 July 2021

Appointed Nawana, Namal as Director

21 July 2021

Resigned Kent-Armes, Helen as Director

1 July 2021

Appointed Brooks, David Graham, Dr as Director

1 July 2020

Appointed Kent-Armes, Helen as Director

10 October 2018

Appointed Armes, Niall Antony as Director

Ownership 0 active

People and entities with significant control, from the Companies House PSC register

The company has declared that it has no person with significant control.

Former controllers (1)

21 July 2021

Ceased Niall Antony Armes — Owns 75–100% of shares

Financials

Balance sheet as at 31 December 2024 · full accounts

Net Assets: (£24,728,537)
Cash: £91,865
Turnover: £923,059
Profit Before Tax: (£8,277,263)
Employees: 87

Debt Ratio: 462%
Current Ratio: 1.6x
Profit Margin: -897%

Balance sheet detail

	2024
Fixed Assets	£2,019,255
Current Assets	£4,813,216
Cash	£91,865
Creditors (< 1 year)	£2,967,404
Creditors (> 1 year)	£28,593,604
Net Current Assets	£1,845,812
Net Assets	(£24,728,537)
Shareholder Funds	(£24,728,537)

Turnover	£923,059
Gross Profit	£923,059
Admin Expenses	£7,323,978
Staff Costs	£5,925,830
Operating Profit	(£8,279,527)
Profit Before Tax	(£8,277,263)
Tax	£332,041
Profit for Period	(£8,609,304)

Filings 50

Date	Description	Made Up To
28 October 2026	Termination of appointment of a director
28 October 2026	Confirmation statement with no updates	9 October 2026
24 September 2026	Termination of appointment of a director
24 September 2026	Termination of appointment of a director
30 December 2025	Full accounts	31 December 2024